Fact CheckerSign in

NCT07170865Not yet recruiting

Dynamic Impact of NIV on Diaphragmatic Ultrasound in Patients With Amyotrophic Lateral Sclerosis

Assessment of the Dynamic Impact of Non-Invasive Ventilation on Diaphragmatic Ultrasound in Patients With Amyotrophic Lateral Sclerosis

Source: ClinicalTrials.gov · Last updated 12 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The goal of this pilot observational study is to learn about the dynamic impact of the non invasive ventilation on the diaphragm in patient with amyotrophic lateral sclerosis. The main question it aims to answer : can diaphragmatic ultrasound detect differences in diaphragmatic motion (diaphragmactic excursion and diaphragmatic thickening between spontaneous breathing and non-invasive ventilation ? Participants will receive diaphragmatic ultrasound assessments both under spontaneous breathing and during non-invasive ventilation on their day hospital evaluation for ventilatory support.

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
20 (estimated)
First submitted
19 Aug 2025
Start date
1 Sept 2025
Primary completion date
15 Sept 2026
Lead sponsor
University Hospital, Grenoble
NCT number
NCT07170865

What you commit to

  • Study type: Observational
  • Planned participants: 20
  • From 1 Sept 2025 to the primary completion date, 15 Sept 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Continuous (24-hour) non-invasive ventilation
  • Patient refusal to participate
  • Individual under legal guardianship or judicial protection

Who the study is looking for

  • Adult patient (≥18 years old)
  • Diagnosis of bulbar or spinal amyotrophic lateral sclerosis (ALS) established by a neurologist
  • Indication for non-invasive ventilation (NIV) confirmed by the referring pulmonologist for daytime and/or nocturnal alveolar hypoventilation

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
CHU Grenoble Alpes
Coordinator of this site? Confirm its status
GrenobleFranceUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.